Compare ABCL & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | LGIH |
|---|---|---|
| Founded | 2012 | 2003 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2020 | 2013 |
| Metric | ABCL | LGIH |
|---|---|---|
| Price | $3.05 | $55.73 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | $7.75 | ★ $75.90 |
| AVG Volume (30 Days) | ★ 3.8M | 322.7K |
| Earning Date | 01-01-0001 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.12 |
| Revenue | $28,833,000.00 | ★ $1,705,504,000.00 |
| Revenue This Year | $26.18 | $18.38 |
| Revenue Next Year | $13.51 | $7.73 |
| P/E Ratio | ★ N/A | $17.78 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.89 | $39.70 |
| 52 Week High | $6.52 | $77.38 |
| Indicator | ABCL | LGIH |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 47.89 |
| Support Level | $3.06 | $58.78 |
| Resistance Level | $3.24 | $63.66 |
| Average True Range (ATR) | 0.21 | 2.96 |
| MACD | -0.01 | -0.67 |
| Stochastic Oscillator | 39.68 | 33.14 |
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.